Home United States USA — IT US FDA grants emergency use authorisation to Regeneron antibody therapy given to...

US FDA grants emergency use authorisation to Regeneron antibody therapy given to Donald Trump

21
0
SHARE

The green light for drugmaker Regeneron came after REGEN-COV2, was shown to reduce COVID-19-related hospitalizations or emergency room visits in patients with …
The green light for drugmaker Regeneron came after REGEN-COV2, was shown to reduce COVID-19-related hospitalizations or emergency room visits in patients with underlying conditions A sign for the Food And Drug Administration is seen outside of the headquarters in White Oak, Maryland. AFP A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren’t yet hospitalized by the disease but are at high risk. The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce COVID-19 -related hospitalizations or emergency room visits in patients with underlying conditions. “Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system,” said Stephen Hahn, commissioner of the Food and Drug Administration (FDA). Leonard Schleifer, Regeneron’s president, and CEO, added the move was “an important step in the fight against COVID-19, as high-risk patients in the United States will have access to a promising therapy early in the course of their infection.

Continue reading...